Is change is the new normal?




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Is change is the new normal?
Released on: June 09, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Andreas Neumann, head of HR at Boehringer Ingelheim discusses the impact their recent deal with Sanofi has had on Human Resources, and how to address the company’s strategic needs from a people perspective.
  • Summary
  • Transcript
  • Participants
  • Company
Andreas Neumann, head of HR at Boehringer Ingelheim discusses the impact their recent deal with Sanofi has had on Human Resources, and how to address the company’s strategic needs from a people perspective.
Andreas Neumann, head of HR at Boehringer Ingelheim discusses the impact their recent deal with Sanofi has had on Human Resources, and how to address the company’s strategic needs from a people perspective.
Dr Andreas Neumann
Boehringer Ingelheim
Boehringer Ingelheim GmbH is a pharmaceutical company which concentrates on the development of human pharmaceuticals, biopharmaceuticals, chemicals, and animal health products. The Human Pharmaceuticals sector is the company's largest division, accounting for about 96% of sales. This includes prescription medicines and consumer healthcare products.